Protein influence on early heart development could lead to better regenerative therapies

April 5, 2017, Agency for Science, Technology and Research (A*STAR), Singapore
Protein influence on early heart development could lead to better regenerative therapies
Studies of heart development in zebrafish embryos could lead to new stem cell therapies. Credit: Philipp Keller, Bill Lemon, Yinan Wan and Kristin Branson, Janelia Farm Research Campus, Howard Hughes Medical Institute, Ashburn, Va. 

Stem cell therapies could one day help repair heart tissue in people with cardiovascular disease. But before doctors feel confident enough to transplant these potent cells into patients, they need to better understand how heart stem cells work normally in the developing embryo. A team of researchers from Singapore and Canada have shown that a receptor needed for early heart development works through intermediate signaling molecules to modulate the activity of a key determinant of cell fate.

A detailed understanding of this molecular cross-talk could help in the derivation of specific cell types from human for regenerative medicine, says Bruno Reversade, a human geneticist at the A*STAR Institute of Medical Biology, who co-led the investigation.

The zebrafish has emerged as a powerful scientific model for studying and function. From the outside, the differences between the hearts of zebrafish and humans may seem substantial, but the two species have strong similarities at the genetic and morphological levels. Because zebrafish embryos are transparent, they provide a tractable system for watching heart development in action.

Reversade teamed up with Ian Scott from the University of Toronto to examine the link between zebrafish born with no heart due to a mutation in a gene that encodes a cell-surface GPCR called the Apelin receptor. They knew that these fish had defective heart stem cells, but it wasn't clear why.

The researchers looked into the expression of genes targeted by another protein called Nodal, a known master regulator of . They found that zebrafish without a working Apelin receptor had lower levels of Nodal target gene expression at the stage of embryonic formation when Nodal activity would normally induce heart stem cells to form. However, experimentally elevating levels of the Apelin receptor increased the expression of these same targets. What's more, directly boosting Nodal activity in zebrafish that lacked the Apelin receptor was sufficient to help them develop beating hearts.

The Apelin receptor and Nodal don't seem to be working in the same , though. As Reversade and Scott showed, the Apelin receptor modulated Nodal signaling through two Nodal ligands, called Squint and Cyclops. Thus, the Apelin receptor seems to serve as kind of a distant rheostat for fine-tuning the Nodal pathway during the earliest stages of heart development.

Future research will help determine how turning the knob on the expression level of the Apelin receptor can aid human patients with congenital diseases.

Explore further: Novel hormone essential for heart development discovered

More information: Ashish R Deshwar et al. The Apelin receptor enhances Nodal/TGFβ signaling to ensure proper cardiac development, eLife (2016). DOI: 10.7554/eLife.13758

Related Stories

Novel hormone essential for heart development discovered

December 6, 2013
Scientists at A*STAR's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat ...

Researchers uncover a hormone that plays a vital role in heart development

March 12, 2014
Hormones—regulatory biochemicals produced by the body—were first identified over 100 years ago. Since then, improvements in researchers' understanding of the key role that hormones play as chemical messengers in processes ...

New insights into the development of the heart

March 26, 2013
Viewed from the outside, our body looks completely symmetrical. However, most internal organs – including the heart – are formed asymmetrically. The right side of the heart is responsible for pulmonary circulation; the ...

Researchers find the link between heart and blood cells in early development

October 7, 2016
New research from the University of Minnesota reveals endoglin as a critical factor in determining the fate of early undifferentiated cells during development. Endoglin, a receptor involved in cell signaling, has previously ...

Recommended for you

Physical activity necessary to maintain heart-healthy lifestyle

September 24, 2018
Exercise and physical activity are of vast global importance to prevent and control the increasing problem of heart disease and stroke, according to a review paper published today in the Journal of the American College of ...

Height may be risk factor for varicose veins, study finds

September 24, 2018
The taller you are, the more likely you are to develop varicose veins, according to a study led by Stanford University School of Medicine researchers that examined the genes of more than 400,000 people in search of clues ...

Prosthetic valve mismatches common in transcatheter valve replacement, ups risk of death

September 24, 2018
In the largest multi-institutional study to date, led by researchers from Penn Medicine, the team found that among patients who underwent a transcatheter aortic valve replacement (TAVR), a high number experienced severe and ...

Study reveals a promising alternative to corticosteroids in acute renal failure treatment

September 21, 2018
A protein produced by the human body appears to be a promising new drug candidate to treat conditions that lead to acute renal failure. This is shown by a study conducted at São Paulo State University (UNESP) in São José ...

Can a common heart condition cause sudden death?

September 20, 2018
About one person out of 500 has a heart condition known as hypertrophic cardiomyopathy (HCM). This condition causes thickening of the heart muscle and results in defects in the heart's electrical system. Under conditions ...

New drugs could reduce risk of heart disease when added to statins

September 20, 2018
New drugs that lower levels of triglycerides (a type of fat) in blood could further reduce the risk of heart attack when added to statins. These new drugs, which are in various stages of development, could also reduce blood ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.